#VisualAbstract: Rituximab plus lenalidomide shows comparable survival compared to chemotherapy for CD20⁺ follicular lymphoma

byTeddy Guo

October 19, 2022

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract: Pembrolizumab provides survival benefit in PD-L1 positive advanced head and neck cancer

RelatedReports

Autologous hematopoietic stem cell transplantation associated with long-term remission in myasthenia gravis

Chronic Disease

Single dose of rituximab for new-onset myasthenia gravis associated with reduced risk of disease manifestations – The RINOMAX Randomized Clinical Trial

September 28, 2022

Mutation linked with decrease in cutaneous diffuse large B-cell lymphoma

Chronic Disease

Lisocabtagene maraleucel improves survival for relapsed or refractory large B-cell lymphoma

June 29, 2022

StudyGraphics

#VisualAbstract: Solid organ transplant recipients are at an increased risk of developing non-melanoma skin cancers

April 12, 2022

StudyGraphics

#VisualAbstract: Adding four doses of rituximab did not significantly improve event-free survival over standard of care in acute lymphoblastic leukaemia

April 8, 2022

Fine needle biopsy remains a reliable test for thyroid cancer diagnosis

Cervical conization may double risk of preterm birth

Anti-VEGF therapy for retinopathy of prematurity may be associated with pulmonary hypertension risk

Atrial fibrillation-specific management increases days alive and out of hospital

Artificial intelligence algorithm may increase atrial fibrillation detection rate in ambulatory setting

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

#VisualAbstract: Rituximab plus lenalidomide shows comparable survival compared to chemotherapy for CD20⁺ follicular lymphoma

Single dose of rituximab for new-onset myasthenia gravis associated with reduced risk of disease manifestations – The RINOMAX Randomized Clinical Trial

Lisocabtagene maraleucel improves survival for relapsed or refractory large B-cell lymphoma

#VisualAbstract: Solid organ transplant recipients are at an increased risk of developing non-melanoma skin cancers

#VisualAbstract: Pembrolizumab provides survival benefit in PD-L1 positive advanced head and neck cancer

Fine needle biopsy remains a reliable test for thyroid cancer diagnosis

RelatedReports

Single dose of rituximab for new-onset myasthenia gravis associated with reduced risk of disease manifestations – The RINOMAX Randomized Clinical Trial

Lisocabtagene maraleucel improves survival for relapsed or refractory large B-cell lymphoma

#VisualAbstract: Solid organ transplant recipients are at an increased risk of developing non-melanoma skin cancers

#VisualAbstract: Adding four doses of rituximab did not significantly improve event-free survival over standard of care in acute lymphoblastic leukaemia

Fine needle biopsy remains a reliable test for thyroid cancer diagnosis

Anti-VEGF therapy for retinopathy of prematurity may be associated with pulmonary hypertension risk

Artificial intelligence algorithm may increase atrial fibrillation detection rate in ambulatory setting

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written
medical news?

#VisualAbstract: Rituximab plus lenalidomide shows comparable survival compared to chemotherapy for CD20⁺ follicular lymphoma

RELATED REPORTS

#VisualAbstract: Pembrolizumab provides survival benefit in PD-L1 positive advanced head and neck cancer

Fine needle biopsy remains a reliable test for thyroid cancer diagnosis

RelatedReports

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written medical news?

Want more physician-written
medical news?